Attached files
| file | filename |
|---|---|
| EX-10.39 - EXHIBIT 10.39 - WEST PHARMACEUTICAL SERVICES INC | ex1039distributoragreement.htm |
| EX-32.2 - EXHIBIT 32.2 - WEST PHARMACEUTICAL SERVICES INC | ex322cfo906certification_2.htm |
| EX-32.1 - EXHIBIT 32.1 - WEST PHARMACEUTICAL SERVICES INC | ex321ceo906certification_2.htm |
| EX-31.2 - EXHIBIT 31.2 - WEST PHARMACEUTICAL SERVICES INC | ex312cfo302certification_2.htm |
| EX-31.1 - EXHIBIT 31.1 - WEST PHARMACEUTICAL SERVICES INC | ex311ceo302certification_2.htm |
| EX-21 - EXHIBIT 21 - WEST PHARMACEUTICAL SERVICES INC | ex21listofsubsidiaries_2016.htm |
| EX-10.40 - EXHIBIT 10.40 - WEST PHARMACEUTICAL SERVICES INC | ex1040licenseagreement_2016.htm |
| 10-K - 10-K - WEST PHARMACEUTICAL SERVICES INC | wst10k123116.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Forms S-3 (Registration Nos. 333-88358 and 333-128438) and Forms S-8 (Registration Nos. 333-106977, 333-115175, 333-143129, 333-156492, 333-171453, 333-174153 and 333-211088) of West Pharmaceutical Services, Inc. of our report dated February 28, 2017 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
Philadelphia, Pennsylvania
February 28, 2017